|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/32 |
| (11) | Number of the document | 2513148 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10791036.6 |
| Date of filing the European patent application | 2010-12-15 | |
| (97) | Date of publication of the European application | 2012-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/060533 |
| Date | 2010-12-15 |
| (87) | Number | WO 2011/084496 |
| Date | 2011-07-14 |
| (30) | Number | Date | Country code |
| 287155 P | 2009-12-16 | US |
| (72) |
HARDING, Fiona A., US
AKAMATSU, Yoshiko, US
DUBRIDGE, Robert B., US
POWERS, David B., US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | ANTI-HER2 ANTIBODIES AND THEIR USES |
| ANTI-HER2 ANTIBODIES AND THEIR USES |